0002007317-24-000219.txt : 20240227 0002007317-24-000219.hdr.sgml : 20240227 20240227162239 ACCESSION NUMBER: 0002007317-24-000219 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 24687144 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: VAN NOSTRAND ROBERT L CENTRAL INDEX KEY: 0001225198 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC. STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 144 1 primary_doc.xml 144 0001225198 XXXXXXXX LIVE 0001567514 Intra-Cellular Therapies, Inc. 001-36274 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344 VAN NOSTRAND ROBERT L Director stock options Merrill Lynch

75 Rockefeller Plaza New York NY 10019

20000 1457387.19 96807191 02/27/2024 NASDAQ STOCK OPTIONS 03/21/2014 COMPENSATION ROBERT VAN NOSTRAND N 20000 02/27/2024 COMPENSATION Y 02/27/2024 ROBERT L VAN NOSTRAND